23
November
2017
|
06:00
Europe/London

Nanobots pass first stage in ‘fantastic voyage’ from fiction to fact

A team of scientists have created a new generation of tiny remote controlled nanorobots which could one day allow doctors to diagnose disease and deliver drugs from within the human body.

The team led by Professor Li Zhang from the Chinese University of Hong Kong, including Professor Kostas Kostarelos from The University of Manchester, have created the bots from a biodegradable material called spirulina algae.

The algae, sold today as a food substitute in health food shops, was a source of nourishment during the time of the Aztecs.

But it was rediscovered in the 1960s by Lake Texcoco in Mexico by French researchers.

A paper by the team, published in Science Robotics hails the bots’ biodegradability as a new concept, in which an iron magnetic coating helps fine-tune the rate which they degrade.

The nanorobots can be remotely controlled within complex biological fluids with high precision using magnetic fields.

The team also describes how the bots are able to release potent drug compounds that are able to attack cancer cells.

However more work still needs to be done on motion tracking, biocompatibility, biodegradation, and diagnostic and therapeutic effects before clinical trials can take place.

Professor Zhang said: “Rather than fabricate a functional microrobot from scratch using intricate laboratory techniques and processes, we set out to directly engineer smart materials in nature, which are endowed with favorable functionalities for medical applications owing to their intrinsic chemical composition. For instance, because these biohybrid bots have a naturally fluorescent biological interior and magnetic iron-oxide exterior, we can track and actuate a swarm of those agents inside the body quite easily using fluorescence imaging and magnetic resonance imaging.

“Our microrobots have the ability to sense changes in environments associated with the onset of illness and that makes them a promising probe for remote diagnostic sensing of diseases.

“We must now develop this technology further so we are able to fine tune this image–guided therapy and create a proof of concept for the engineering of multifunctional microrobotic and nanorobotic devices.”

Creating robotic systems which can be propelled and guided in the body has been and still is a holy-grail in the field of delivery system engineering. Our work takes advantage of some elements offered by nature such as fluorescence, degradability, shape. But we add engineered features such as magnetisation and biological activity to come up with a the proof-of-concept behind our bio-hybrid, magnetically propelled microrobots.
Professor Kostas Kostarelos

Professor Kostarelos said: “Creating robotic systems which can be propelled and guided in the body has been and still is a holy-grail in the field of delivery system engineering.

“Our work takes advantage of some elements offered by nature such as fluorescence, degradability, shape.

“But we add engineered features such as magnetisation and biological activity to come up with a the proof-of-concept behind our bio-hybrid, magnetically propelled microrobots.

He added: “We are still in early days of development since any such robotic system would need to be either completely and safely degraded, or it will need to be removed or excreted from the body after it has finished its work.

“But nevertheless, our work provides the first ever example of how this could be possibly achieved by degradation.

“The potential of these bots for controlled navigation in hard-to-reach cavities of the human body makes them promising miniaturized robotic tools to diagnose and treat diseases which is minimally invasive.”

The research teram included the Chinese University of Hong Kong, The  University of Edinburgh and The University of Manchester.

The paper ‘Multifunctional biohybrid magnetite microrobots for imaging-guided therapy’ is published in Science Robotics (DOI: 10.1126/scirobotics.aaq1155) on 22 November, 2017.

Share this release